Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 12 Oct 2022 |
2 | Reply to Exam Report (MIS-R) | 18 Aug 2023 |
3 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 01 Sep 2023 |
4 | Documents in support of Show cause Hearing (SCH) | 07 Sep 2023 |
5 | Authorization Letter | 18 Apr 2024 |
6 | Journal Copy | 08 Aug 2024 |
7 | Certificate | 28 Sep 2024 |
1 | EXAMINATION REPORT | 15799404 | 09 Aug 2023 | |
2 | Hearing Notice (Show Cause) | 17793908 | 21 Mar 2024 | |
3 | Tribunal Accepted Notice for : 5643270 | 18083966 | 6715425 | 01 May 2024 |
The application for Syn dilclofenac was made on 12 October 2022.
The trademark applicant for Syn dilclofenac is SYNCOM FORMULATIONS INDIA.
Syn dilclofenac is applied in class(es) 5.
Application for Syn dilclofenac is on Registered stage.
Application Id allotted to Syn dilclofenac is 5643270.
Trademark agent or attorney for the application is Navkar Associates.
Syn dilclofenac filed with the Intellectual property office as a DEVICE.